Literature DB >> 33144429

Co-implantation of Tumor and Extensive Surrounding Tissue Improved the Establishment Rate of Surgical Specimens of Human-Patient Cancer in Nude Mice: Toward the Goal of Universal Individualized Cancer Therapy.

Takuya Murata1, Chihiro Hozumi2, Yukihiko Hiroshima3, Koichiro Shimoya4, Atsushi Hongo5, Sachiko Inubushi6, Hirokazu Tanino6, Robert M Hoffman7,8.   

Abstract

BACKGROUND/AIM: The discovery of the nude mouse model enabled the experimental growth of human-patient tumors. However, the low establishment rate of tumors in nude and other immunodeficient strains of mice has limited wide-spread clinical use.
MATERIALS AND METHODS: In order to increase the establishment rate of surgical specimens of patient tumors, we transplanted tumors to nude mice subcutaneously along with large amounts of surrounding tissue of the tumor.
RESULTS: The new transplantation method increased the establishment rate in nude mice to 66% compared to the old method of implanting the surgical tumor specimen with surrounding tissue removed (14%). High stage and presence of metastasis in the patient donor are positively correlated to tumor engraftment in nude mice.
CONCLUSION: The new method can potentially allow most cancer patients who undergo surgery or biopsy to have their own mouse model for drug-sensitivity testing. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  PDX; Patient-derived xenograft; breast cancer; co-implantation; gynecological cancer; individualized medicine; nude mice; patient-derived orthotopic xenograft (PDOX); surrounding tissue; take rate; tumor implantation

Mesh:

Year:  2020        PMID: 33144429      PMCID: PMC7811650          DOI: 10.21873/invivo.12160

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  17 in total

1.  Tumor heterogeneity and personalized medicine.

Authors:  Dan L Longo
Journal:  N Engl J Med       Date:  2012-03-08       Impact factor: 91.245

2.  Cancer modeling meets human organoid technology.

Authors:  David Tuveson; Hans Clevers
Journal:  Science       Date:  2019-06-07       Impact factor: 47.728

3.  Cervical Cancer Patient-Derived Orthotopic Xenograft (PDOX) Is Sensitive to Cisplatinum and Resistant to Nab-paclitaxel.

Authors:  Takashi Murakami; Takuya Murata; Kei Kawaguchi; Tasuku Kiyuna; Kentaro Igarashi; Ho Kyoung Hwang; Yukihiko Hiroshima; Chihiro Hozumi; Shin Komatsu; Takashi Kikuchi; Thinzar M Lwin; Jonathan C Delong; Kentaro Miyake; Yong Zhang; Kuniya Tanaka; Michael Bouvet; Itaru Endo; Robert M Hoffman
Journal:  Anticancer Res       Date:  2017-01       Impact factor: 2.480

4.  Development of the Histoculture Drug Response Assay (HDRA).

Authors:  Robert M Hoffman; Robert A Vescio
Journal:  Methods Mol Biol       Date:  2018

5.  NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells.

Authors:  Mamoru Ito; Hidefumi Hiramatsu; Kimio Kobayashi; Kazutomo Suzue; Mariko Kawahata; Kyoji Hioki; Yoshito Ueyama; Yoshio Koyanagi; Kazuo Sugamura; Kohichiro Tsuji; Toshio Heike; Tatsutoshi Nakahata
Journal:  Blood       Date:  2002-11-01       Impact factor: 22.113

6.  Patient-derived orthotopic xenograft models of sarcoma.

Authors:  Kentaro Igarashi; Kei Kawaguchi; Takashi Murakami; Kentaro Miyake; Tasuku Kiyuna; Masuyo Miyake; Yukihiko Hiroshima; Takashi Higuchi; Hiromichi Oshiro; Scott D Nelson; Sarah M Dry; Yunfeng Li; Norio Yamamoto; Katsuhiro Hayashi; Hiroaki Kimura; Shinji Miwa; Shree Ram Singh; Hiroyuki Tsuchiya; Robert M Hoffman
Journal:  Cancer Lett       Date:  2019-10-19       Impact factor: 8.679

7.  Models of human metastatic colon cancer in nude mice orthotopically constructed by using histologically intact patient specimens.

Authors:  X Y Fu; J M Besterman; A Monosov; R M Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

Review 8.  Organoids in cancer research.

Authors:  Jarno Drost; Hans Clevers
Journal:  Nat Rev Cancer       Date:  2018-07       Impact factor: 60.716

9.  Clinical applications of the histoculture drug response assay.

Authors:  T Furukawa; T Kubota; R M Hoffman
Journal:  Clin Cancer Res       Date:  1995-03       Impact factor: 12.531

10.  The identification of candidate effective combination regimens for pancreatic cancer using the histoculture drug response assay.

Authors:  Eunsung Jun; Yejong Park; Woohyung Lee; Jaewoo Kwon; Song Lee; Moon Bo Kim; Ji Sun Lee; Ki Byung Song; Dae Wook Hwang; Jae Hoon Lee; Robert M Hoffman; Song Cheol Kim
Journal:  Sci Rep       Date:  2020-07-20       Impact factor: 4.379

View more
  1 in total

1.  The First Mouse Model of Meckel's Diverticulum Carcinoma.

Authors:  Noriyuki Masaki; Yutaka Yonemura; Nathaniel F Wu; Carissa Samonte; Chihiro Hozumi; Yutaro Kubota; Yusuke Aoki; Michael Bouvet; Jun Miyazaki; Robert M Hoffman
Journal:  In Vivo       Date:  2022 Jul-Aug       Impact factor: 2.406

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.